Pablo G. Legorreta - May 7, 2021 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
CEO, Chairman of the Board, Director
Signature
/s/ Jason Mehar, as Attorney-in-Fact for Pablo G. Legorreta
Stock symbol
RPRX
Transactions as of
May 7, 2021
Transactions value $
$0
Form type
4
Date filed
5/11/2021, 09:03 PM
Previous filing
Apr 15, 2022
Next filing
Jun 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Conversion of derivative security $0 +1.04M $0.00 1.04M May 7, 2021 By Legorreta Children 2002 Trust F1
transaction RPRX Class A Ordinary Shares Conversion of derivative security $0 +1.28M $0.00 1.28M May 7, 2021 By GST-Exempt Legorreta 2012 Family Trust F1
holding RPRX Class A Ordinary Shares 10K May 7, 2021 By Child
holding RPRX Class A Ordinary Shares 10K May 7, 2021 By Child
holding RPRX Class A Ordinary Shares 123K May 7, 2021 By IRRA
holding RPRX Class A Ordinary Shares 119K May 7, 2021 By SEP/IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPRX LP interests in RPI US Partners 2019, LP Conversion of derivative security $0 -104K -100% $0.00* 0 May 7, 2021 Class A Ordinary Shares 1.04M $0.00 By Legorreta Children 2002 Trust F1, F2
transaction RPRX LP interests in RPI US Partners 2019, LP Conversion of derivative security $0 -128K -100% $0.00* 0 May 7, 2021 Class A Ordinary Shares 1.28M $0.00 By GST-Exempt Legorreta 2012 Family Trust F1, F2
holding RPRX LP interests in RPI US Partners 2019, LP 147K May 7, 2021 Class A Ordinary Shares 1.47M $0.00 By Spouse F2
holding RPRX LP interests in RPI US Partners 2019, LP 2.85M May 7, 2021 Class A Ordinary Shares 28.5M $0.00 By Legorreta Investments LLC F2, F3
holding RPRX LP interests in RPI US Partners 2019, LP 2.86M May 7, 2021 Class A Ordinary Shares 28.6M $0.00 By Legorreta Investments II LLC F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.
F2 Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.
F3 The Reporting Person has agreed to retain and not sell 3,743,242 RPI US LP Interests convertible into 37,432,420 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.